Diabetes drug maker being sued for the death it has caused Australians
Yet another drug company getting sued for not fully disclosing the deadly side effects of a drug it made billions from. How do these people look in the mirror or sleep?
Law firm Maurice Blackburn said it would join a class action against Takeda and Eli Lilly, the co-manufacturers and distributors of the drug. Maurice Blackburn Principal Damian Scattini said the companies had behaved “Terribly. They knew before they even released the drug that it had a tendency to induce tumours in rats but they proceeded irrespective of that. The science is terrible for the defendant and what they did is terrible”
The Disgraceful Bottom Line
- There have been more than 1.7 million Australian prescriptions for Actos in the past four years
- Actos has been linked to a 40% increased risk of bladder cancer after patients have been taking it for between one and two years
- Consumers in France and Germany were no longer exposed to the drug as it had been taken off the market
- In America a black-box warning said long-term use was linked to bladder cancer
- In Australia and New Zealand the drug was still available and did not have the same full bladder cancer warnings
As reported by The Sydney Morning Herald on May 20, 2013.